LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)

NCT01198054 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
4
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

PETHEMA Foundation